Home » Topics » Science » New compound

New compound
RSS

LU-135252 improves pulmonary hypertension in rats

May 10, 1996

P&U reports most potent K(ATP)-channel blocker yet discovered

May 10, 1996

RS-66252 selective for AT1 receptors in vitro

May 10, 1996

Antihypertensive activity reported for FR-149581

May 10, 1996

R-844: Novel steroid for asthma

May 10, 1996

GR-175737: H3 antagonist for cognition disorders

May 10, 1996

DuPont Merck discloses HIV protease inhibitors

May 10, 1996

Academic investigators report potential anti-HIV agents

May 10, 1996

U-31355: potent HIV-1 RTase inhibitor

May 10, 1996

Nichinichi reports novel approach to antifungal Rx

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Beone eyes Huahui Health’s trispecific HH-160 with $2B option deal
BioWorld
Beone Medicines Ltd. gained an exclusive option to develop cancer immunotherapy HH-160 worldwide in a deal potentially worth more than $2 billion for Huahui...
Unique trial strategy muddies the ODAC waters for camizestrant
BioWorld
Following a discussion that focused more on a new personalized trial strategy rather than the proposed therapy, the U.S. FDA’s Oncologic Drugs Advisory Committee...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...